本臨床試驗的目標是了解 SUPPORT+（一款數碼症狀監測及自我管理手機應用程式）能否改善接受紓緩治療的晚期癌症成年患者的健康相關生活質素及臨床結局。 本研究旨在回答的主要問題包括： * 與常規紓緩治療相比，使用 SUPPORT+ 是否有助維持或改善健康相關生活質素？ * SUPPORT+ 能否減少功能衰退
適應症：Palliative Care、Advanced Cancer
收案條件
納入條件
- Adults aged 18 years or older
- Diagnosis of advanced malignancy
- Decision not to pursue further systemic anticancer treatment
- Receiving follow-up care at a participating palliative care clinic
- Community-dwelling
- Ownership of a smartphone
- Adequate cognitive capacity to provide informed consent
- Willingness to receive notifications from the SUPPORT+ mobile application
- Presence of at least one symptom related to advanced cancer
- Ability for the patient or a designated primary caregiver to use the mobile application
排除條件
- Receiving systemic anticancer therapy with radical or palliative intent
- Estimated life expectancy of less than 3 months
- Eastern Cooperative Oncology Group (ECOG) performance status greater than 3
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。